Psychedelic Business Spotlight – March 18
This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.
MINDCURE
Mind Cure Health Halts All Psychedelic Business Activity
The company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers.
How Psychedelic Treatment Through Canada’s SAP Works
Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.
Psychedelic Companies HAVN Life Sciences, MINDCURE Health Reach Manufacturing Milestones
The global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.
End of content
End of content